Tacrolimus CAS NO.104987-11-3

Send Inquiry
Tacrolimus CAS NO.104987-11-3
Details
microbial metabolites; signal transduction pathway kinase inhibitor; dermatosis skin beauty class; API; macrolide antibiotics; plant extracts; small molecule inhibitors CGMP
Category
Tacrolimus API
Share to
Description

Basic information

Product Name:

Tacrolimus

Synonyms:

16-dimethoxy-4,10,12,18-tetramethyl-8-3-(2-(4-hydroxy-3-methoxycyclohexyl)-1;15,19-Epoxy-3H-pyrido[2,1-c][1,4]oxaazacyclotricosine-1,7,20,21(4H,23H)-tetrone,5,6,8,11,12,13,14,15,16,17,18,19,24,25,26,26a-hexadecahydro-5,19-dihydroxy-3-[2-(4-hydroxy-3-methoxycyclohexyl)-1-methylethenyl]-14,16-dimethoxy-4,10,12,18-tetramethyl-8-(2-propenyl)-,[3S-[3R*[E(1S*,3S*,4S*)],4S*,5R*,8S*,9E,12R*,14R*,15S*,16R*,18S*,19S*,26aR*]]-;L679934;Protopic;Fujimycin;Prozraf

CAS:

104987-11-3

MF:

C44H69NO12

MW:

804.02

 

Physical and chemical properties

Melting point

113-115°C

Boiling point

871.7

Density

1.19

Flash Point

481.0 ℃

Appearance

White or grayish white crystalline powde

 

Usage

Uses

A macrolide that binds to FK506 binding protein (FKBP) to form a complex, thereby reducing the activity of peptidylprolyl isomerase in T cells

 

Tacrolimus, also known as FK506, is a kind of macrolide antibiotic isolated from Streptomyces. It is a powerful new immunosuppressant. It can inhibit the release of interleukin-2 (IL-2) and inhibit T lymphocyte completely. It is 100 times stronger than CSA. In recent years, as the first-line drug for liver and kidney transplantation, it has been listed in 14 countries such as Japan and the United States. Clinical experiments show that it has a good effect in heart, lung, intestine, bone marrow transplantation. At the same time, FK506 also plays an active role in the treatment of atopic dermatitis (AD), systemic lupus erythematosus (SLE), autoimmune ophthalmopathy and other autoimmune diseases.

Hot Tags: tacrolimus cas no.104987-11-3, China, manufacturers, suppliers, factory, custom, wholesale

Send Inquiry